SUSMED,Inc. (4263.T)

JPY 519.0

(3.8%)

Market Cap (In JPY)

8.72 Billion

Revenue (In JPY)

342.57 Million

Net Income (In JPY)

-357.41 Million

Avg. Volume

98.23 Thousand

Currency
JPY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
375.0-1399.0
PE
-13.57
EPS
-38.25
Beta Value
1.5
ISIN
JP3319150003
CUSIP
-
CIK
-
Shares
16806752.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Healthcare
CEO
Mr. Taro Ueno
Employee Count
-
Website
https://www.susmed.co.jp
Ipo Date
2021-12-24
Details
SUSMED,Inc. develops and sells therapeutic applications in Japan. It develops smartphone based digital therapeutics applications for diseases with insomnia, breast cancer, and kidney disease. The company also develops and sells development platform for therapeutic apps and clinical trial systems. In addition, it offers medical data analysis and consulting services. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.